Mapping Genetic Variation

The 1000 Genomes Project reveals the most comprehensive catalog to date of variation in the human genome.

Written byEd Yong
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Flickr, Tonio VegaAn international consortium of scientists known as the 1000 Genomes Project has published a long-awaited map of variation in the human genome, cataloging the subtle differences that shape our bodies and influence our risk of disease. The results, published today (31 October) in Nature, were derived from the genome sequences of 1,092 volunteers hailing from 14 populations in Europe, East Asia, Africa, and the Americas. They should help scientists more efficiently hunt for the genetic causes of disease, by comparing mutations in a patient’s genome against those seen in his own country or ethnic group.

"The 1000 genomes project is the backbone of our understanding for human variation,” said Ewan Birney from the European Bioinformatics Institute, who is not part of the consortium. “Both the data and the methods will be reused many times in the forthcoming decade.”

The 1000 Genomes Project takes advantage of the dramatically falling cost of genome sequencing—and even contributed to the continued reduction of those costs by increasing demand. The pilot phase, published in 2010, had already documented most of the common variants found in more than 5 percent of people. In the new study, the researchers focused on the world’s rarer variants, by sequencing every nucleotide in the volunteers’ exome about 50 to 100 times over. (The rest of participants’ DNA was also sequenced, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies